| EU Biotech Development Limited |
| Registered number: |
SC199767 |
| Balance Sheet |
| as at 28 February 2022 |
|
| Notes |
|
|
2022 |
|
|
2021 |
| £ |
£ |
| Fixed assets |
| Tangible assets |
3 |
|
|
87,971 |
|
|
117,295 |
|
| Current assets |
| Cash at bank |
|
|
589,663 |
|
|
859,467 |
|
| Creditors: amounts falling due within one year |
4 |
|
(568,219) |
|
|
(620,277) |
|
| Net current assets |
|
|
|
21,444 |
|
|
239,190 |
|
| Total assets less current liabilities |
|
|
|
109,415 |
|
|
356,485 |
|
| Creditors: amounts falling due after more than one year |
5 |
|
|
- |
|
|
(190,965) |
|
|
|
| Net assets |
|
|
|
109,415 |
|
|
165,520 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
10,000 |
|
|
10,000 |
| Profit and loss account |
|
|
|
99,415 |
|
|
155,520 |
|
| Shareholders' funds |
|
|
|
109,415 |
|
|
165,520 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| M S Choung |
| Director |
| Approved by the board on 25 August 2022 |
|
| EU Biotech Development Limited |
| Notes to the Accounts |
| for the year ended 28 February 2022 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
| 2 |
Employees |
2022 |
|
2021 |
| Number |
Number |
|
|
Average number of persons employed by the company |
3 |
|
3 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Tangible fixed assets |
|
|
|
|
|
|
|
|
Plant and machinery etc |
| £ |
|
Cost |
|
At 1 March 2021 |
156,393 |
|
At 28 February 2022 |
156,393 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 March 2021 |
39,098 |
|
Charge for the year |
29,324 |
|
At 28 February 2022 |
68,422 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 28 February 2022 |
87,971 |
|
At 28 February 2021 |
117,295 |
|
|
| 4 |
Creditors: amounts falling due within one year |
2022 |
|
2021 |
| £ |
£ |
|
|
Trade creditors |
544,118 |
|
608,518 |
|
Corporation tax |
8,194 |
|
8,194 |
|
Other creditors |
15,907 |
|
3,565 |
|
|
|
|
|
|
568,219 |
|
620,277 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Creditors: amounts falling due after one year |
2022 |
|
2021 |
| £ |
£ |
|
|
Other creditors |
- |
|
190,965 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Other information |
|
|
EU Biotech Development Limited is a private company limited by shares and incorporated in Scotland. Its registered office is: |
|
1 George Square |
|
Glasgow |
|
G2 1AL |
